116 related articles for article (PubMed ID: 12558763)
1. Platelet 3H ketanserin binding in tension-type headache.
Shukla R; Husain M; Tandon R; Khanna VK; Nag D; Dikshit M; Srimal RC; Seth PK
Headache; 2003 Feb; 43(2):103-8. PubMed ID: 12558763
[TBL] [Abstract][Full Text] [Related]
2. Platelet 3H ketanserin binding in migraine.
Shukla R; Khanna VK; Pradeep S; Husain M; Tandon R; Nag D; Dikshit M; Srimal RC; Seth PK
Cephalalgia; 2001 Jun; 21(5):567-72. PubMed ID: 11472383
[TBL] [Abstract][Full Text] [Related]
3. Non-serotonergic 3H-ketanserin binding sites in human platelets: characteristics and interaction with calcium antagonists.
Oliva D; Pocchiari F; Allievi L; Rovati GE; Nicosia S
Pharmacol Res; 1992 Sep; 26(2):187-99. PubMed ID: 1409259
[TBL] [Abstract][Full Text] [Related]
4. High-affinity binding of [3H]6-nitroquipazine to 5-hydroxytryptamine transporter in human platelets.
Hashimoto K; Goromaru T
Eur J Pharmacol; 1990 Oct; 187(3):295-302. PubMed ID: 2073917
[TBL] [Abstract][Full Text] [Related]
5. Serotonin metabolism in chronic tension-type headache.
Bendtsen L; Jensen R; Hindberg I; Gammeltoft S; Olesen J
Cephalalgia; 1997 Dec; 17(8):843-8. PubMed ID: 9453272
[TBL] [Abstract][Full Text] [Related]
6. Effect of fluvoxamine on 5-hydroxytryptamine uptake, paroxetine binding sites and ketanserin binding sites in the Japanese monkey brain and platelets, in vivo and in vitro.
Goto S; Egashira T; Wada Y; Takayama F; Yamanaka Y
Jpn J Pharmacol; 1996 Aug; 71(4):291-8. PubMed ID: 8886926
[TBL] [Abstract][Full Text] [Related]
7. Characterization of serotonin binding sites on human platelets.
McBride PA; Mann JJ; McEwen B; Biegon A
Life Sci; 1983 Nov; 33(20):2033-41. PubMed ID: 6645789
[TBL] [Abstract][Full Text] [Related]
8. Binding characteristics of [3H]ketanserin for serotonin-2 receptor in the rabbit platelet.
Tsuchihashi H; Yagi N; Kimura M; Shirota K; Kinami J; Nagatomo T
J Pharmacobiodyn; 1991 Aug; 14(8):461-6. PubMed ID: 1663547
[TBL] [Abstract][Full Text] [Related]
9. Solubilized ketanserin binding sites from pig platelet membranes.
Wesemann W; Hoffmann D
Thromb Res; 1985 Sep; 39(6):693-700. PubMed ID: 2934860
[TBL] [Abstract][Full Text] [Related]
10. Identification of non-serotonergic [3H]ketanserin binding sites on human platelets and their role in serotonin release.
Leysen JE; Gommeren W; Janssen PA
Eur J Pharmacol; 1991 Jan; 206(1):39-45. PubMed ID: 2065715
[TBL] [Abstract][Full Text] [Related]
11. Inhibition and dissociation of [3H]-paroxetine binding to human platelets.
Andersson A; Marcusson J
Neuropsychobiology; 1989; 22(3):135-40. PubMed ID: 2535005
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of S2-receptor binding sites on cat blood platelets using [3H]ketanserin.
Leysen JE; Gommeren W; De Clerck F
Eur J Pharmacol; 1983 Mar; 88(1):125-30. PubMed ID: 6852103
[TBL] [Abstract][Full Text] [Related]
13. 5-HT2 serotonin receptor on blood platelet of migraine patients.
Govitrapong P; Limthavon C; Srikiatkhachorn A
Headache; 1992 Nov; 32(10):480-4. PubMed ID: 1468904
[TBL] [Abstract][Full Text] [Related]
14. Estradiol-induced increase of specific [3H]ketanserin binding sites on rat uterine membranes.
Ichida S; Hayashi T; Kita T; Murakami T
Eur J Pharmacol; 1985 Feb; 108(3):257-64. PubMed ID: 3157585
[TBL] [Abstract][Full Text] [Related]
15. [3H]ketanserin binds to non-5-HT2 sites in rabbit cerebral cortex and neostriatum.
Dewar KM; Lima L; Reader TA
Neurochem Res; 1990 May; 15(5):507-14. PubMed ID: 2115148
[TBL] [Abstract][Full Text] [Related]
16. Characterization of serotonin receptors in the iris + ciliary body of the albino rabbit.
Mallorga P; Sugrue MF
Curr Eye Res; 1987 Mar; 6(3):527-32. PubMed ID: 3581873
[TBL] [Abstract][Full Text] [Related]
17. Characterization of two [3H]ketanserin recognition sites in rat striatum.
Roth BL; McLean S; Zhu XZ; Chuang DM
J Neurochem; 1987 Dec; 49(6):1833-8. PubMed ID: 2960784
[TBL] [Abstract][Full Text] [Related]
18. The 5-hydroxytryptamine receptor of blood platelets.
Pletscher A; Affolter H
J Neural Transm; 1983; 57(4):233-42. PubMed ID: 6655466
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological profiles of R-96544, the active form of a novel 5-HT2A receptor antagonist R-102444.
Ogawa T; Sugidachi A; Tanaka N; Fujimoto K; Asai F
Eur J Pharmacol; 2002 Dec; 457(2-3):107-14. PubMed ID: 12464356
[TBL] [Abstract][Full Text] [Related]
20. AT-1015, a newly synthesized 5-HT2 receptor antagonist, dissociates slowly from the 5-HT2 receptor sites in rabbit cerebral cortex membrane.
Rashid M; Watanabe M; Nakazawa M; Nagatomo T
J Pharm Pharmacol; 2002 Aug; 54(8):1123-8. PubMed ID: 12195828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
